Treating pain has long been a challenge. Over-the-counter treatments often don’t do enough, while opioids block pain signals ...
Looking at options history for Vertex Pharmaceuticals (NASDAQ: VRTX) we detected 10 trades. If we consider the specifics of ...
Vertex Pharmaceuticals’ CRISPR-based therapy made history as the first drug of its type, transforming care options for sickle ...
StockStory.org on MSN
Vertex Pharmaceuticals (VRTX): Buy, Sell, or Hold Post Q2 Earnings?
Over the past six months, Vertex Pharmaceuticals’s stock price fell to $413.23. Shareholders have lost 12.5% of their capital ...
Zacks Investment Research on MSN
Here's Why Vertex Pharmaceuticals (VRTX) Fell More Than Broader Market
In the latest close session, Vertex Pharmaceuticals (VRTX) was down 1.49% at $414.86. The stock's performance was behind the S&P 500's daily loss of 0.28%. Meanwhile, the Dow lost 0.52%, and the ...
The Rasmussen Reports daily Presidential Tracking Poll for Wednesday shows that 48% of Likely U.S. Voters approve of President Trump’s job performance. Fifty (50%) disapprove. The latest figures ...
President Trump on Monday night announced tariffs of 10% on softwood timber and lumber alongside a 25% tariff on "certain upholstered wooden products" due to take effect on October 14, according to ...
Vertex Pharmaceuticals has been a clear winner in the pharmaceutical sector. Over the past two decades, this powerhouse has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback